Diabetes induces changes of catecholamines in primary mesangial cells

International Journal of Biochemistry and Cell Biology

Volumn 40, Issue 4, 2008, Pages 747-754

  Marco, Giovana Seno Di ^a   Colucci, Juliana Almada ^b   Fernandes, Fernanda Barrinha ^b   Vio, Carlos Pablo ^c   Schor, Nestor ^b   Casarini, Dulce Elena ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Catecholamine; Diabetes; Mesangial cell; Nonobese diabetic mice

Indexed keywords

CATECHOLAMINE; TETRAHYDROBIOPTERIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE METABOLISM; CELL ISOLATION; CONTROLLED STUDY; DIABETES MELLITUS; DOPAMINE RELEASE; ENZYME DEGRADATION; ENZYME SYNTHESIS; FEMALE; GLOMERULUS; HYPERGLYCEMIA; KIDNEY DISEASE; MESANGIUM CELL; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; NORADRENALIN RELEASE; PATHOGENESIS; RECEPTOR UPREGULATION;

ANIMALS; BIOPTERIN; CATECHOLAMINES; CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; DOPAMINE; FEMALE; KIDNEY; MESANGIAL CELLS; MICE; MICE, INBRED NOD; MONOAMINE OXIDASE; NOREPINEPHRINE; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; MUS;

EID: 39649084200     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2007.10.016     Document Type: Article

References (19)

1. Adeghate E., and Parvez H. The effect of diabetes mellitus on the morphology and physiology of monoamine oxidase in the pancreas. Neurotoxicology 25 (2004) 167-173
2. Adeghate E., Ponery A.S., and Sheen R. Streptozotocin-induced diabetes mellitus is associated with increased pancreatic tissue levels of noradrenaline and adrenaline in the rat. Pancreas 22 (2001) 311-316
3. Arita D.Y., Di Marco G.S., Schor N., and Casarini D.E. Purification and characterization of the active form of tyrosine hydroxylase from mesangial cells in culture. Journal of Cellular Biochemistry 87 (2002) 58-64
4. Barthelmebs M., Mayer P., Thomas A., Grima M., and Imbs J.L. Pathophysiological role of dopamine in the kidney: effects in diabetes mellitus and contralateral nephrectomy. Hypertension Research 18 (1995) S131-S136
5. Carranza A., Karabatas L., Barontini M., and Armando I. Decreased tubular uptake of l-3,4-dihydroxyphenylalanine in streptozotocin-induced diabetic rats. Hormone Research 55 (2001) 282-287
6. Di Marco G.S., Naffah-Mazzacoratti Md M.G., Vio C.P., Dos Santos O.F., Schor N., and Casarini D.E. Mesangial cells are able to produce catecholamines in vitro. Journal of Cellular Biochemistry 89 (2003) 144-151
7. Fowler J.S., Logan J., Wang G.J., Franceschi D., Volkow N.D., Telang F., et al. Monoamine oxidase A imaging in peripheral organs in healthy human subjects. Synapse 49 (2003) 178-187
8. Ganguly P.K., Beamish R.E., Dhalla K.S., Innes I.R., and Dhalla N.S. Norepinephrine storage, distribution, and release in diabetic cardiomyopathy. American Journal of Physiology 252 (1987) E734-E739
9. Gupta B.L., Nehal M., and Baquer N.Z. Effect of experimental diabetes on the activities of hexokinase, glucose-6-phosphate dehydrogenase and catecholamines in rat erythrocytes of different ages. Indian Journal of Experimental Biology 35 (1997) 792-795
10. Jeansson M., Granqvist A.B., Nyström J.S., and Haraldsson B. Functional and molecular alterations of the glomerular barrier in long-term diabetes in mice. Diabetologia 49 (2006) 2200-2209
11. Lackovic Z., Salkovic M., Kuci Z., and Relja M. Effect of long-lasting diabetes mellitus on rat and human brain monoamines. Journal of Neurochemistry 54 (1990) 143-147
12. Lakhman S.S., and Kaur G. Effect of experimental diabetes on monoamine oxidase activity from discrete areas of rat brain: relationship with diabetes associated reproductive failure. Molecular and Cellular Biochemistry 177 (1997) 15-20
13. Leese G.P., and Vora J.P. The management of hypertension with special reference to diabetic kidney desease. Diabetic Medicine 13 (1996) 401-410
14. Luippold G., Beilharz M., and Muhlbauer B. Reduction of glomerular hyperfiltration by dopamine D(2)-like receptor blockade in experimental diabetes mellitus. Nephrology Dialysis Transplantation 16 (2001) 1350-1356
15. Patel K.P., Zhang K., Hein M., and Mayhan W.G. Peripheral noradrenergic turnover in streptozotocin-induced diabetic rats. Diabetes Research and Clinical Practice 35 (1997) 1-9
16. Pfeil K., Staudacher T., and Luippold G. Effect of l-dopa decarboxylase inhibitor benserazide on renal function in streptozotocin-diabetic rats1. Kidney Blood Pressure Research 29 (2006) 43-47
17. Pizzinat N., Marchal-Victorion S., Maurel A., Ordener C., Bompart G., and Parini A. Substrate-dependent regulation of MAO-A in rat mesangial cells: involvement of dopamine D2-like receptors. American Journal of Physiology-Renal Physiology 284 (2003) F167-F174
18. Umrani D.N., and Goyal R.K. Beneficial effects of fenoldopam treatment on renal function in streptozotocin-induced diabetic rats. Clinical and Experimental Hypertension 24 (2002) 207-219
19. Zeng C., Zhang M., Asico L.D., Eisner G.M., and Jose P.A. The dopaminergic system in hypertension. Clinical Science (London) 112 (2007) 583-597